Overview

Comparing Effect of Topical Tacrolimus 0.03% Versus Cyclosporine 0.05% in Dry Eyes of Secondary Sjogren Syndrome

Status:
Completed
Trial end date:
2019-04-30
Target enrollment:
Participant gender:
Summary
Evaluation of the effect of topical application of Tacrolimus 0.03% (FK506) eye drops versus Cyclosporine 0.05% eye drops in treatment of dry eye in Secondary Sjogren Syndrome.
Phase:
Phase 3
Details
Lead Sponsor:
Pavly Moawd
Treatments:
Cyclosporine
Cyclosporins
Ophthalmic Solutions
Tacrolimus